| Miss Maria C Arzubiaga, MD | |
|
3400 Lebanon Rd, Murfreesboro, TN 37129-1237 | |
| (615) 893-1360 | |
| (615) 867-5788 |
| Full Name | Miss Maria C Arzubiaga |
|---|---|
| Gender | Female |
| Speciality | Dermatology - Procedural Dermatology |
| Location | 3400 Lebanon Rd, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225117476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | MD0000018676 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Maria C Arzubiaga, MD 2873 Sugar Tree Rd, Nashville, TN 37215-1909 Ph: (615) 385-4650 | Miss Maria C Arzubiaga, MD 3400 Lebanon Rd, Murfreesboro, TN 37129-1237 Ph: (615) 893-1360 |
News Archive
Half-facepiece reusable elastomeric respirators are an effective and viable option for protecting health care workers from exposure to airborne transmissible contaminants or infectious agents - for example, influenza virus - during day-to-day work or with a sudden or rapid influx of patients, such as during a public health emergency, says a new report from the National Academies of Sciences, Engineering, and Medicine.
Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.
› Verified 8 days ago
S Kathleen Clark, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1132 Dow St, Murfreesboro, TN 37130 Phone: 615-896-2617 | |
Andrea Jurgens, MD, MPH Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1725 Medical Center Pkwy Ste 300, Murfreesboro, TN 37129 Phone: 615-893-4100 | |
Dr. Henry King Butler Jr., MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 515 Highland Terrace, Suite A, Murfreesboro, TN 37130 Phone: 615-890-0827 Fax: 615-890-0828 | |
Dr. Ronald Andrew Nelson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 515 Highland Ter, Suite A, Murfreesboro, TN 37130 Phone: 615-904-2010 Fax: 615-904-6285 | |
Dr. Christopher Brady Bledsoe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1430 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-893-4480 | |
Dr. Charles Edward Goodman Jr., MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 320 East Main Street, Murfreesboro, TN 37130 Phone: 615-896-5772 Fax: 615-907-7389 |